CMEA Capital caters seed, early, and later stage venture, private equity, and debt financing investments and is based in California.
Business Model:
Revenue: $14.1M
Employees: 2-10
Address: 1 Letterman Dr
City: San Francisco
State: CA
Zip: 94129
Country: US
CMEA closed in April of 2015 and has unveiled its new corporate identity as [Presidio Partners](https://www.crunchbase.com/organization/presidio-partners). CMEA Capital is a venture capital firm with a clear focus on life sciences, high technology, and energy and materials investments. We believe that the most successful venture backed companies are those that are science based, with experienced teams that have a vision. As a result, CMEA typically invests in companies that have cutting edge and highly differentiated technology at their core and founding teams of the highest caliber still in place. These are companies that have the potential to transform their industries. CMEA Capital was founded in 1989 and maintains offices in San Francisco and Menlo Park. We invest in both early and late stage science-focused ventures, and leverage a strong network of corporate, investment, and entrepreneurial relationships on behalf of portfolio companies. Our partners and associates have extensive science, engineering, and operational backgrounds, providing us the confidence to look beyond today&s;s technology. We apply our focus on science and teams to our collaborations with entrepreneurs and venture investment partners who are changing the world, one great company at a time.
Contact Phone:
+14153521520
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2004 | Liveops | Series B | 22M |
11/2008 | Evolution Robotics | Series B | 13.9M |
8/2000 | Syrrx | Series A | 5.1M |
12/2004 | Intermolecular | Series A | 424k |
2/2006 | AWR Corporation | Venture Round | 0 |
11/2006 | Alien Technology | Venture Round | 50M |
5/2008 | Multigig | Series B | 12.5M |
5/2011 | Jobvite | Series C | 15M |
12/2006 | Untangle | Series A | 10.5M |
8/2006 | TrueDemand Software | Series B | 8M |
4/2015 | Cnano Technology | Series B | 0 |
10/2014 | Jobvite | Series D | 0 |
7/2013 | Mojo Networks | Series D | 0 |
12/2007 | Jobvite | Series A | 7.2M |
7/2009 | Blekko | Series C | 11.5M |
12/2009 | Solaria | Debt Financing | 0 |
5/2008 | Untangle, Inc. | Series B | 8M |
5/2009 | Visiogen | Series D | 40M |
2/2007 | Liveops | Series C | 28M |
12/2011 | Graffiti Labs | Seed Round | 1.6M |
5/2014 | Arcadia Biosciences | Series D | 0 |
11/2006 | Kalypsys | Series C | 100M |
2/2008 | InSound Medical | Series E | 11M |
11/2008 | Danotek Motion Technologies | Series A | 14.5M |
10/2009 | Foro Energy | Venture Round | 25M |
1/2010 | Cnano Technology | Series B | 7M |
9/2009 | Jobvite | Series B | 8.3M |
4/2009 | Ambrx | Series D | 10M |
6/2008 | Ardelyx | Series A | 26.1M |
10/2007 | Relypsa | Series A | 33M |
7/2009 | Schooner Information Technology | Series B | 20M |
12/2010 | Multigig | Series C | 10M |
3/2008 | NuScale Power | Venture Round | 2.6M |
4/2012 | WorkingPoint | Venture Round | 188k |
8/2011 | Ardelyx | Series B | 30M |
1/2007 | Telsima | Venture Round | 50M |
5/2014 | Sorbent Therapeutics | Series D | 0 |
6/2011 | Sorbent Therapeutics | Series B | 0 |
12/2005 | Agility Design Solutions | Series B | 7M |
4/2013 | Spitfire Pharma | Venture Round | 0 |
12/2009 | Danotek Motion Technologies | Venture Round | 13.2M |
9/2010 | Sorbent Therapeutics | Series B | 0 |
8/2006 | Codexis | Series D | 0 |
8/2008 | Triporati | Venture Round | 6M |
12/2008 | Contour Energy | Series A | 10.8M |
4/2012 | Bionic Panda Games | Venture Round | 800k |
9/2011 | Blekko | Venture Round | 30M |
9/2011 | Beautylish | Angel Round | 1M |
1/2006 | Perlegen Sciences | Series D | 0 |
2/2005 | Perlegen Sciences | Series D | 0 |
10/2011 | Contour Energy | Series C | 20M |
10/2005 | Raven Biotechnologies | Series D | 48.3M |
1/2009 | Intermolecular | Series D | 20M |
1/2009 | Superprotonic | Series C | 8M |
7/2010 | Luminate | Series B | 12M |
7/2006 | Ambrx | Series C | 52M |
8/2008 | Tetraphase Pharmaceuticals | Series A | 0 |
8/2008 | Schooner Information Technology | Series A | 15M |
12/2005 | Telsima | Series C | 20M |
8/2011 | Danotek Motion Technologies | Series B | 15M |
9/2007 | Netbooks | Series A | 6.9M |
6/2006 | Pyxis Technology | Series B | 9.2M |
5/2015 | VYNE Therapeutics | Series A | 14.3M |
12/2008 | Symwave | Series C | 10.2M |
7/2008 | Amitive | Series A | 10M |
3/2007 | Phenomix | Series C | 55M |
4/2007 | Mojo Networks | Series C | 0 |
4/2009 | Pyxis Technology | Series C | 3M |
11/2013 | MediaSpike | Series A | 5.2M |
2/2012 | Luminate | Series C | 10.7M |
3/2014 | Neos Therapeutics | Series C | 15.5M |
4/2008 | SpikeSource | Series C | 20M |
11/2012 | Auspex Pharmaceuticals | Series D | 0 |
10/2010 | Auspex Pharmaceuticals | Series C | 12M |
6/2010 | Baxano | Series C | 30M |
1/2014 | Auspex Pharmaceuticals | Series E | 0 |
2/2008 | TrueDemand Software | Series C | 2.7M |
12/2008 | Solyndra | Series E | 220M |
3/2002 | Sanera Systems | Venture Round | 10M |
9/2000 | Sanera Systems | Series A | 17.5M |
10/2006 | Strix Systems | Series G | 7M |
7/2009 | Intellikine | Series B | 51M |
7/2007 | Cnano Technology | Series A | 6M |
3/2013 | RSI (Reel Solar Inc) | Seed Round | 4M |
3/1997 | Silicon Spice | Series A | 3.3M |
2/2010 | Contour Energy | Series B | 14.2M |
10/2001 | Sanera Systems | Series B | 38.3M |
11/2009 | Blekko | Series C | 2.5M |
6/2005 | Intermolecular | Series B | 10.1M |
9/2006 | Intermolecular | Series C | 27.6M |
7/2012 | MediaSpike | Seed Round | - |
3/2009 | Luminate | Series A | 5.8M |
10/2011 | Zaarly | Series A | 14.2M |
6/2010 | Tetraphase Pharmaceuticals | Series C | 0 |
4/2005 | Teros | Series D | 0 |
3/2008 | Luminus Devices | Series E | 72M |
5/2015 | VYNE Therapeutics | Series A | 0 |
4/2015 | Cnano Technology | Series B | 0 |
10/2014 | Jobvite | Series D | 0 |
5/2014 | Sorbent Therapeutics | Series D | 0 |
5/2014 | Arcadia Biosciences | Series D | 0 |
3/2014 | Neos Therapeutics | Series C | 0 |
1/2014 | Auspex Pharmaceuticals | Series E | 0 |
11/2013 | MediaSpike | Series A | 0 |
7/2013 | Mojo Networks | Series D | 0 |
4/2013 | Spitfire Pharma | Venture Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|